Grower's Secret
OperatingGROWER'S SECRET, INC.
Healthcare · Honolulu, HI
Grower’s Secret empowers farmers to be better stewards of their farms. Since 1998, we’ve manufactured organic crop inputs that replace synthetic nitrogen with sustainable alternatives. Now, you can invest in this vision of farming and own a piece of the Grower’s Secret.
Financials
FY2023–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Fundraising history
Team
3 people
Chaz Berman is a seasoned serial entrepreneur and the CEO of Grower’s Secret, his eighth business venture. His prior success includes helping take MyPoints (MYPT) public ( eventually reaching a market cap of $2.5 billion. Chaz holds a BA from Case Western Reserve University and an MS in Marketing from San Francisco State University.
Kirk Misaka, CFO of Grower’s Secret, is a former KPMG partner with over 20 years advising flagship clients and leading multi-billion-dollar M&A deals. He’s also helped scale two tech startups to successful exits, including one that grew to $280M in revenue across 20 countries.
Albert Pleus is a director, advisor, and/or principal of a diverse set of businesses. He has over 30 years of experience in a variety of enterprises. Mr. Pleus started his career at Morgan Stanley, and has since focused on advisor and principal investment roles in early stage companies. He sits on a number of boards, including two non-profits. Mr. Pleus earned bachelor’s and master’s degrees from the Massachusetts Institute of Technology and an MBA from Stanford University.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 1 annual reports (FY2025)
Missing: 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGAR- Form CNov 5, 20250001138738-25-000005EDGAR
- Form DFeb 5, 20150001138738-15-000001EDGAR
- Form DFeb 5, 20150001138738-15-000002EDGAR
- Form DFeb 5, 20150001138738-15-000003EDGAR
- Form DNov 21, 20110001138738-11-000009EDGAR
- Form DNov 18, 20110001138738-11-000008EDGAR
- Form DMar 21, 20110001138738-11-000004EDGAR
- Form DMar 21, 20110001138738-11-000003EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.